Nicolina C. Sorrentino
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
TRPML1 agonists synergize with enzyme replacement therapy in fibroblasts from Pompe disease patients.
Journal: Journal of translational medicine
Published: March 10, 2026
Retina-specific long non-coding RNAs associated with inherited retinal disease genes.
Journal: Cellular and molecular life sciences : CMLS
Published: February 13, 2026
A coordinated transcriptional program controls de novo Golgi biogenesis.
Journal: The EMBO journal
Published: November 17, 2025
Commentary: Lysosomal enzymes engineered to cross the blood-brain barrier are reshaping the therapeutic landscape of neuronopathic mucopolysaccharidoses.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: October 16, 2025
Hepatocyte delivery of miR-34b/c reduces hepatic stellate cell activation and improves liver fibrosis.
Journal: Molecular therapy. Nucleic acids
Published: July 21, 2024
Anti-amyloid treatment is broadly effective in neuronopathic mucopolysaccharidoses and synergizes with gene therapy in MPS-IIIA.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 03, 2024
Safe and effective liver-directed AAV-mediated homology-independent targeted integration in mouse models of inherited diseases.
Journal: Cell reports. Medicine
Published: October 04, 2023
Role of trafficking protein particle complex 2 in medaka development.
Journal: Traffic (Copenhagen, Denmark)
Published: August 07, 2023
Increased expression or activation of TRPML1 reduces hepatic storage of toxic Z alpha-1 antitrypsin.
Increased expression or activation of TRPML1 reduces hepatic storage of toxic Z alpha-1 antitrypsin.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 19, 2023
Frequency-Dependent Squeezed Vacuum Source for the Advanced Virgo Gravitational-Wave Detector.
Journal: Physical review letters
Published: February 12, 2023
The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage Disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 19, 2022
TFEB and TFE3 drive kidney cystogenesis and tumorigenesis.
Journal: EMBO molecular medicine
Published: September 13, 2022
Last Updated: 09/26/2026